• Press Office

    Posted in category News Release by Press Office on 15/11/2013

    ABPI Pharmaceutical Ophthalmology Initiative (POPI) comments on the RNIB’s report into capacity in eye care services.

Commenting on the RNIB’s report on capacity in eye care services, ‘Saving Money, Losing Sight’, the Chair of the POPI, Joe Brice, said: “We welcome the publication of the RNIB’s report which demonstrates the unsustainable direction in which ophthalmic services are heading.The lack of capacity in eye care is a long-standing issue, exacerbated by the ageing population and rising prevalence of conditions like diabetes".


 Joe added: "This necessitates decisive action from policy makers to ensure that eye care services are capable of meeting increasing demand. The RNIB has demonstrated that there is no room for complacency; no one should lose their sight because of delays to their treatment and care.  For too long eye health has not been seen as a priority and in far too many areas of the country this is still the case.

"The advent of the Public Health Outcomes Framework indicator on preventing avoidable sight loss is a positive development, but its intentions will not be realised fully as long as these systemic issues with eye care services remain.  It is astounding that only 36% of Joint Strategic Needs Assessments (JSNAs) include a specific section on sight loss and eye health – and even more alarming that in some cases commissioners are building their plans based on JSNAs that have no reference to eye health.

"The POPI group wholeheartedly supports the RNIB’s recommendations and hopes that NHS England will heed the report’s calls for a National Clinical Director and an inquiry into the quality of ophthalmic care. We are committed to working with key stakeholders to improve the care that patients receive and we hope that this report will encourage all involved to collaborate at both a national and a local level to safeguard the future of eye care services.”

Media enquiries

ABPI Press Office
Tel: +44 (0) 20 7747 1441
Mobile: +44 (0) 7808 641 811 
Email: pressoffice@abpi.org.uk

Notes to editor:

ABPI Pharmaceutical Ophthalmology Initiative (POPI) is formed of ABPI member companies with an interest in eye health. Its objective is to work with others to raise the standard of eye care and deliver the best possible outcomes for patients across the UK. Bausch + Lomb, MSD, Bayer and Novartis are members of the group and JMC Partners provides the secretariat.

Print this page icon Print this page
Please choose the subject of your enquiry from the list below:
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.